XML 46 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Taxes  
Income Taxes

13.Income Taxes

The components of loss before income taxes are as follows:

Year Ended December 31, 

(in thousands)

    

2023

    

2022

    

2021

Domestic

$

(238,272)

$

(291,746)

$

(287,058)

Foreign

 

 

(8)

 

(42)

Total

$

(238,272)

$

(291,754)

$

(287,100)

For the periods presented, the income tax provision (benefit) is as follows:

Year Ended December 31, 

(in thousands)

    

2023

    

2022

    

2021

Current:

 

  

 

  

 

  

Federal

$

$

$

State

 

 

 

Foreign

 

 

 

Subtotal

$

$

$

 

  

 

  

 

  

Deferred:

 

  

 

  

 

  

Federal

$

(380)

$

$

State

 

 

 

Foreign

 

 

 

Subtotal

$

(380)

$

$

 

  

 

  

 

  

Income tax provision (benefit)

$

(380)

$

$

There was no income tax provision in 2022 and 2021 due to the Company’s history of losses and valuation of allowances against the deferred tax assets.  

A reconciliation of the statutory United States federal rate to the Company’s effective tax rate is as follows:

Year Ended December 31, 

 

    

2023

    

2022

    

2021

  

Percent of pre-tax income:

 

  

 

  

 

  

United States federal statutory income tax rate

 

21.0

%  

21.0

%  

21.0

%

State taxes, net of federal benefit

 

(1.2)

 

1.7

 

2.6

Foreign rate differences

 

 

 

Permanent items

 

(0.1)

 

0.2

Research and development credit

 

0.9

 

1.8

 

2.6

Stock-based compensation costs

(3.5)

(2.3)

(1.2)

Other

 

0.7

 

 

Change in valuation allowance

(17.7)

 

(22.1)

 

(25.2)

Effective income tax rate

 

0.2

%  

%  

%

The components of the Company’s net deferred tax assets as of December 31, 2023 and 2022 consist of the following:

December 31, 

(in thousands)

    

2023

    

2022

Net operating loss carryforwards

$

170,402

$

131,423

Research and development credits

 

65,225

 

63,164

Depreciation and amortization

 

37,211

 

51,877

Stock-based compensation

 

30,370

 

32,561

Sales related accruals

 

38,474

 

23,864

Other accruals

 

42,480

 

19,717

Capitalized research and development

46,062

17,673

Gross deferred tax assets

 

430,224

 

340,279

Right-of-use asset

 

(1,538)

 

(1,903)

In-process research and development

 

(6,403)

 

(603)

Gross deferred tax liabilities

 

(7,941)

 

(2,506)

Total net deferred tax asset

 

422,283

 

337,773

Less valuation allowance

 

(423,385)

 

(337,773)

Net deferred tax assets (liabilities)

$

(1,102)

$

The tax benefit of net operating losses, temporary differences and credit carry forwards is recorded as an asset to the extent that management assesses that realization is “more likely than not.” The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the temporary differences representing net future deductible amounts become deductible. Due to the Company’s history of losses, and lack of other positive evidence, the Company has determined that it is more likely than not that its federal net deferred tax assets and certain state net deferred tax assets will not be realized, and therefore, the Company has offset the federal and certain state net deferred tax assets by a valuation allowance as of December 31, 2023 and 2022.

The valuation allowance increased by $85.6 million, $64.4 million and $72.4 million during the years ended December 31, 2023, 2022 and 2021, respectively.

As of December 31, 2023, the Company had net operating loss carryforwards for federal income of $774.9 million, which will start to expire in the year 2036, and various states net operating loss carryforwards of $128.0 million, which have various expiration dates beginning in 2031.

As of December 31, 2023, the Company had federal research and development credit carryforwards for federal income tax purposes of $60.6 million, which will start to expire in the year 2031, and state research and development credit carryforwards of $26.5 million, which have no expiration date.

Utilization of the net operating loss and tax credit carryforwards may be subject to a substantial annual limitation due to ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of certain net operating loss and tax credit carryforwards before their utilization. Under the new enacted tax law, the carry forward period of net operating losses generated from 2018 forward is indefinite. However, the carryforward period for net operating losses generated prior to 2018 remains the same. Therefore, the annual limitation may result in the expiration of certain net operating losses and tax credit carryforwards before their utilization. The Company files income tax returns in the United States federal jurisdiction, various United States state jurisdictions, and a foreign jurisdiction with varying statutes of limitations. The tax years from inception in 2011 forward remain open to examination due to the carryover of unused net operating losses and tax credits.

A reconciliation of the Company’s unrecognized tax benefits during 2023, 2022 and 2021 is as follows:

Year Ended December 31, 

(in thousands)

    

2023

    

2022

    

2021

Balance at beginning of year

$

16,838

$

15,495

$

13,243

Additions based on tax positions related to current year

 

865

 

1,385

 

2,038

Additions (reductions) for tax positions of prior years

 

(286)

 

(42)

 

214

Balance at end of year

$

17,417

$

16,838

$

15,495

As of December 31, 2023, 2022 and 2021, the Company had $17.4 million, $16.8 million and $15.5 million, respectively, of unrecognized benefits, none of which would currently affect the Company’s effective tax rate if recognized due to the Company’s deferred tax assets being fully offset by a valuation allowance. During 2023, 2022 and 2021, the Company did not recognize accrued interest and penalties related to unrecognized tax benefits. The Company does not anticipate a material adjustment of unrecognized tax benefits during the next twelve months from the balance sheet date as reductions for tax positions of prior years.